Translating Research Into Practice
The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
Carolyn Grande,(1) CRNP, Constance Visovsky,(2) PhD, RN, ACNP, and Marcia S. Brose,(1) MD, PhD
(1)Department of Otorhinolaryngology, Hospital of the University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania; (2)University of South Florida College of Nursing, Tampa, Florida
Carolyn Grande, CRNP, Stellar-Chance Laboratories, 422 Curie Blvd, Suite M8D, Philadelphia, PA 19104.
E-mail: Carolyn.Grande@uphs.upenn.edu
J Adv Pract Oncol 2017;8:388–391 |
https://doi.org/10.6004/jadpro.2017.8.4.7 |
© 2017 Harborside Press®
ABSTRACT
There are challenges to conducting rare cancer clinical trials due to issues surrounding clinical trial design, patient recruitment, and analysis of the study outcomes. This article highlights the challenges of research and data analysis in rare cancers and proposes future study directions using less traditional approaches.
For access to the full length article, please
sign in.
